Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1200MG cannabidiol BY capsules twice daily----1件: 46 💬
2400MG cannabidiol BY capsules twice daily----1件: 46 💬
3Abacavir 300MG twice daily1件: Abacavir2件: Abacavir sulfate ,
Abacavir 💬 		--1件: 265 💬
4Acthar GEL 40 units twice weekly----1件: 84 💬
5ALL subjects will receive maraviroc 300MG orally twice A DAY FOR 6 weeks----1件: 84 💬
6Budesonide 0.5MG orodispersible tablet twice daily1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
7Budesonide 1MG orodispersible tablet twice daily1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
8Burosumab
(Burosumab-twza)		1件: Burosumab1件: Burosumab (Burosumab-twza) 💬 1件: FGF23 💬 11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238 💬
9Chinese herbal concoction twice A DAY FOR 6 months----1件: 60 💬
10Colistimethate 75 MG inhaled TWO times daily1件: Colistimethate1件: Colistimethate sodium 💬 --1件: 299 💬
11Combination OF navepegritide and lonapegsomatropin administered AS TWO separate S.C. injections----1件: 276 💬
12Crysvita (burosumab-twza) treatment1件: Burosumab1件: Burosumab (Burosumab-twza) 💬 1件: FGF23 💬 11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238 💬
13ETD001 multiple twice daily doses----1件: 299 💬
14Gentamicin infusions twice A week FOR SIX months1件: Gentamicin2件: Gentamicin sulfate ,
Gentamicin 💬 		--1件: 113 💬
15High dose bibf 1120 twice daily----1件: 85 💬
16Intermediate dose bibf 1120 twice daily----1件: 85 💬
17JNJ-54781532 75 MG twice daily----1件: 97 💬
18LOW dose bibf 1120 twice daily----1件: 85 💬
19Mesalamine twice-daily1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
20Nitrate-rich beetroot juice (70ML with approx. 400 MG nitrate) twice A DAY FOR 3 days1件: Nitrate1件: Nitric acid 💬 --1件: 85 💬
21Oral administration OF 100 MG KH176 twice daily----1件: 21 💬
22Order OF TWO elements OF surgical procedure----1件: 51 💬
23Part 1 levulan surface application twice with microneedling----1件: 34 💬
24PET/CT scan: TWO PET scans using 1. C-11 HED and 2. N-13 ammonia or rubidium-82----1件: 86 💬
25PRX-102 1 MG/KG every TWO weeks----1件: 19 💬
26Tobi™ podhaler™ 112 MG inhaled twice daily----1件: 299 💬
27Tofacitinib 5 MG twice daily1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 84 💬
28Treatment OF MTX and twhf----1件: 46 💬
29Treatment OF twhf----1件: 46 💬
30Twhf----1件: 46 💬
31Twice daily 90 MG hydrocortisone acetate suppository administered with sephure applicator3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
32Twice-daily dosage with 0.5% cyclosporine-A eyedrops----1件: 90 💬